Drug and Therapy Development for Triple Negative Breast Cancer
Wiley-VCH (Verlag)
978-3-527-35175-6 (ISBN)
In »Drug and Therapy Development for Triple Negative Breast Cancer«, a team of distinguished practitioners delivers an in-depth and authoritative discussion of contemporary methods for treating triple negative breast cancer (TNBC). The editors have included material that covers its molecular causes, initial detection, diagnostic tools, treatment procedures, pharmacology, and new and experimental therapies—including nanotherapeutics and photothermal therapies.
As the first comprehensive compilation of modern treatment methods for TNBC, this reference is an unmatched source of information about current and future treatment approaches, including machine learning methods for earlier detection and more accurate diagnosis. Readers will also find:
- A thorough introduction to HER receptors in breast cancers
- Comprehensive explorations of the etiology and therapy of hormone receptor-positive breast cancer and the early-stage diagnosis of breast cancer
- Application of artificial intelligence to breast cancer diagnosis
- New insights on the role of DNA replication stress and genome instability in breast cancer
Perfect for medicinal and pharmaceutical chemists, Drug and Therapy Development for Triple Negative Breast Cancer will also benefit oncologists and professionals working in the pharmaceutical industry or in hospital settings.
Dr. Pravin Kendrekar, School of Natural Sciences, University of Central Lancashire, Preston, UK.Dr. Vinayak Adimule, Angadi Institute of Technology and Management, Belagavi, India.Dr. Tara Hurst, Pandemic Sciences Institute, University of Oxford, Oxford, UK.
HISTORY OF BREAST CANCER
Early-Stage Diagnosis of Breast Cancer: Amelioration in Approaches
DNA replication stress and genome instability in breast cancer
Recent advancement of nanotherapeutics to treat breast cancer
HER Receptor in Breast Cancer
Human endogenous retroviruses in triple negative breast cancer
NOVEL DRUG DISCOVERY AND DEVELOPMENT
Development in Drug repurposing for the treatment of acute leukemia complicating metastatic breast cancer
Novel pharmaceutical nanomaterials to advance the current breast cancer treatment - Current trends and future perspective
ADVANCED TECHNOLOGIES IN BREAST CANCER THERAPY
Artificial intelligence-driven decisions in breast cancer diagnosis
Establishing nanotechnology-based drug development for triple-negative breast cancer treatment
Etiology and therapy of hormone receptor positive breast cancer
Donor-acceptor based heterocyclic compounds as chemotherapy and photothermal agents in treatment of breast cancer cell
REGULATORY, CLINICAL ASPECTS AND CASE STUDIES
An insight into drug regulatory affairs and the procedures
A comprehensive review of some heat shock proteins in the development and progression of human breast cancer
Nanoparticle-based therapeutics for triple negative breast cancer
| Erscheinungsdatum | 19.07.2023 |
|---|---|
| Verlagsort | Weinheim |
| Sprache | englisch |
| Maße | 170 x 244 mm |
| Gewicht | 762 g |
| Einbandart | gebunden |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
| Medizin / Pharmazie ► Pharmazie | |
| Naturwissenschaften ► Chemie | |
| Schlagworte | Brustkrebs • Chemie • Chemistry • Drug Discovery & Development • Drug Discovery & Development • Medical oncology • Medical Science • Medizin • medizinische Onkologie • Pharmacology & Pharmaceutical Medicine • Pharmacology & Pharmaceutical Medicine • Pharmakologie • Pharmakologie u. Pharmazeutische Medizin • Wirkstoffforschung • Wirkstoffforschung u. -entwicklung |
| ISBN-10 | 3-527-35175-2 / 3527351752 |
| ISBN-13 | 978-3-527-35175-6 / 9783527351756 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
